147 related articles for article (PubMed ID: 26300997)
21. DNA Sequencing Methods: From Past to Present.
Eren K; Taktakoğlu N; Pirim I
Eurasian J Med; 2022 Dec; 54(Suppl1):47-56. PubMed ID: 36655445
[TBL] [Abstract][Full Text] [Related]
22. Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems.
Horgan D; Van den Bulcke M; Malapelle U; Troncone G; Normanno N; Capoluongo ED; Prelaj A; Rizzari C; Trapani D; Singh J; Kozaric M; Longshore J; Ottaviano M; Boccia S; Pravettoni G; Cattaneo I; Malats N; Buettner R; Lekadir K; de Lorenzo F; Hofman P; De Maria R
Heliyon; 2024 Jan; 10(1):e23914. PubMed ID: 38234913
[TBL] [Abstract][Full Text] [Related]
23. Next-generation carrier screening: are we ready?
Prior TW
Genome Med; 2014; 6(8):62. PubMed ID: 25473430
[TBL] [Abstract][Full Text] [Related]
24. Editorial: Methods and applications in molecular diagnostics.
Arora N; Chaudhary A; Prasad A
Front Mol Biosci; 2023; 10():1239005. PubMed ID: 37529376
[No Abstract] [Full Text] [Related]
25. Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Hemissi I; Boussetta S; Dallali H; Hellal F; Durand G; Voegele C; Ayed H; Zaghbib S; Naimi Z; Ayadi M; Chebil M; Mckay J; Le Calvez-Kelm F; Ouerhani S
Mol Biol Rep; 2022 Feb; 49(2):1259. PubMed ID: 34977990
[No Abstract] [Full Text] [Related]
26. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
27. Hereditary Colorectal Cancer: Genetics and Screening.
Brosens LA; Offerhaus GJ; Giardiello FM
Surg Clin North Am; 2015 Oct; 95(5):1067-80. PubMed ID: 26315524
[TBL] [Abstract][Full Text] [Related]
28. The Genetics of Colorectal Cancer.
Jasperson K; Burt RW
Surg Oncol Clin N Am; 2015 Oct; 24(4):683-703. PubMed ID: 26363537
[TBL] [Abstract][Full Text] [Related]
29. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
D'Haene N; Le Mercier M; De Nève N; Blanchard O; Delaunoy M; El Housni H; Dessars B; Heimann P; Remmelink M; Demetter P; Tejpar S; Salmon I
PLoS One; 2015; 10(9):e0138245. PubMed ID: 26366557
[TBL] [Abstract][Full Text] [Related]
30. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
[TBL] [Abstract][Full Text] [Related]
31. Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms.
Burghel GJ; Hurst CD; Watson CM; Chambers PA; Dickinson H; Roberts P; Knowles MA
Biomed Res Int; 2015; 2015():478017. PubMed ID: 26351634
[TBL] [Abstract][Full Text] [Related]
32. DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.
Ollier M; Radosevic-Robin N; Kwiatkowski F; Ponelle F; Viala S; Privat M; Uhrhammer N; Bernard-Gallon D; Penault-Llorca F; Bignon YJ; Bidet Y
Am J Cancer Res; 2015; 5(7):2113-26. PubMed ID: 26328243
[TBL] [Abstract][Full Text] [Related]
33. Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review.
Minucci A; Scambia G; Santonocito C; Concolino P; Canu G; Mignone F; Saggese I; Guarino D; Costella A; Molinario R; De Bonis M; Ferrandina G; Petrillo M; Scaglione GL; Capoluongo E
Expert Rev Mol Diagn; 2015; 15(10):1383-403. PubMed ID: 26306726
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
Susswein LR; Marshall ML; Nusbaum R; Vogel Postula KJ; Weissman SM; Yackowski L; Vaccari EM; Bissonnette J; Booker JK; Cremona ML; Gibellini F; Murphy PD; Pineda-Alvarez DE; Pollevick GD; Xu Z; Richard G; Bale S; Klein RT; Hruska KS; Chung WK
Genet Med; 2016 Aug; 18(8):823-32. PubMed ID: 26681312
[TBL] [Abstract][Full Text] [Related]
35. Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing.
Lattimore V; Currie M; Lintott C; Sullivan J; Robinson BA; Walker LC
N Z Med J; 2015 Aug; 128(1419):56-61. PubMed ID: 26365847
[TBL] [Abstract][Full Text] [Related]
36. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
Lin Y; Wu Z; Guo W; Li J
Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
[TBL] [Abstract][Full Text] [Related]
37. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
[TBL] [Abstract][Full Text] [Related]
39. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Ramus SJ; Song H; Dicks E; Tyrer JP; Rosenthal AN; Intermaggio MP; Fraser L; Gentry-Maharaj A; Hayward J; Philpott S; Anderson C; Edlund CK; Conti D; Harrington P; Barrowdale D; Bowtell DD; Alsop K; Mitchell G; ; Cicek MS; Cunningham JM; Fridley BL; Alsop J; Jimenez-Linan M; Poblete S; Lele S; Sucheston-Campbell L; Moysich KB; Sieh W; McGuire V; Lester J; Bogdanova N; Dürst M; Hillemanns P; ; Odunsi K; Whittemore AS; Karlan BY; Dörk T; Goode EL; Menon U; Jacobs IJ; Antoniou AC; Pharoah PD; Gayther SA
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26315354
[TBL] [Abstract][Full Text] [Related]
40. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
